SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-18-001784
Accepted
2018-07-13 00:15:35
Documents
1
Effectiveness Date
2018-07-12
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 592
  Complete submission text file 9999999995-18-001784.txt   1782
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: EFFECT | Act: 33 | File No.: 333-226065 | Film No.: 18951509
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1